Z-2115-2019 Class II Terminated

Recalled by Burlington Medical, LLC — Newport News, VA

FDA device recall Z-2115-2019 was initiated by Burlington Medical, LLC on Jun 7, 2019 and is designated Class II. Reason for recall: The protective material used in the manufacture of the products could potentially provide inadequate protection for the product user. Use of the products could expose the user to scatter radiation of… The recall status is terminated (terminated Apr 28, 2023). Affected quantity: 7.

Recall details

Product Type
Devices
Report Date
Aug 7, 2019
Initiation Date
Jun 7, 2019
Termination Date
Apr 28, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7

Product description

Overlap Vest, Single Item, Product Number FVest, Part Numbers REFVEST*F, REFVEST*M, REFVESTE, REFVESTXLM, SEFVEST*F, SEFVEST*M

Reason for recall

The protective material used in the manufacture of the products could potentially provide inadequate protection for the product user. Use of the products could expose the user to scatter radiation of varying degrees depending on many different variables (e.g., distance, shielding, position, time, kV, etc.). Long-term exposure to scatter radiation may increase the risk of cancer, infertility, or other health-related conditions.

Distribution pattern

US Nationwide distribution. The products were distributed to the following foreign countries: Korea, Thailand.

Code information

Serial Numbers: 385688 387953 385694 385696 387781 384424 382874

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2115-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2115-2019. Report a data issue: hello@regdatalab.com.